- Alzheimer disease
- Charcot-Marie-Tooth disease
- Epilepsy
- Forearm pain
- Gait abnormality
- Guillain-Barre syndrome
- Headache
- Memory disorder
- Mild cognitive impairment
- Movement disorder
- Multiple sclerosis
- Myasthenia gravis
- Nerve pain
- Neurological disorder
- Peripheral neuropathy
- Primary progressive aphasia (PPA)
- Stroke
- Transient ischemic attack
- Traumatic brain injury
David R. Lynch, MD, PhD
Neurology
Independent provider
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
About me
- Professor of Neurology
- Professor of Neurology in Pediatrics
My education and training
- Johns Hopkins University School of MedicineMedical School
- University of Pennsylvania Health SystemResidency
- University of Pennsylvania Health SystemFellowship
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
- Devoted Health Choice Giveback Pennsylvania (PPO)
- Devoted Health Choice Pennsylvania (PPO)
- Devoted Health Choice Plus Pennsylvania (PPO)
- Devoted Health Core Pennsylvania (HMO)
- Devoted Health Dual Plus Pennsylvania (HMO D-SNP)
- Devoted Health Giveback Pennsylvania (HMO)
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Lynch is an independent physician who is not employed by Penn Medicine.
Qualifications and experience
- Neurology, 1993
- American Academy of Neurology, National
- American Neurological Association, International
- Australian Medical Research Council, International
- Cooperative Ataxia Group (CAG), National
- French Government Scientific Review, International
- Friedreich Ataxia Research Alliance, National
- Government, Czech Republic, International
- MDA, National
- NIH RAID Program, National
- NIH, National
- NINDS Committee on Common Data Elements, International
- National Ataxia Foundation, National
- Society for Neuroscience, National
- Cerebrovascular disease care
- General neurology
- Headache and migraine care
- Memory and cognitive disorders care
- Multiple sclerosis and neuroimmunology
- Neurocritical care
- Neuromuscular disorders care
- Peripheral nerve care
- Stroke care
All conditions and treatments
Research
Publications
Elizabeth Mercado-Ayon; Jennifer Coulman; Jia-Ying Lee; Eunjoo Lancaster; Elliot Goga; Mohammad Asad; Eric Witze Impaired Glur2 Palmitoylation in Cerebellar Purkinje Cells of a Friedreich Ataxia Mouse Model , Exp Neurol, 406(115955.): 2026
Lazaropolous, MP, Devore, M, Bidichandani, SJ, LynchD.R. Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletion , Annals of Clinical and Translational Neurology, 13(10): 2026,2134-2137.
Lynch DR, Keita M, Gunther K, Park C, Schadt K, Mercer-Rosa L, Lin KY. Serial assessment of echocardiographic measures in Friedreich ataxia. , Am Heart J Plus, 70(100869.): 2026
Gitman, a., Bhandari, N., Castellano, M, Schadt, K., Cancio, M, Lynch, D. R. Stem cell transplantation in Friedreich ataxia: Cure for Leukemia but no effect on neurological progression , Annals Clinical and Translational Neurol, 13(8): 2026,1733-1735
Lin KY, Bucha A, McSweeney K, Wade KL, Karaj A, Tamaroff J, O'Malley S, Chung NM, Cilenti NA, Wanner J, Adzika GK, Mesaros C, Blair IA, Rojsajjakul T, Serai S, Farmer J, Bryant K, Lu Y, Harhay MO, Weber DR, Paridon SM, Seifert EL, Putt ME, Zamani P, Baur JA, Lynch DR, McCormack SE. Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2x2 factorial, randomised controlled trial. , Lancet Neurol, 25(5): 2026,469-481.
Ali SAH, Early J, Farmer JM, Gelbard S, Corben L, Rance G, Lynch DR. Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia. , Cerebellum, 25(3): 2026,60
Satoshi Miyashita, Anthony Zaki, Kaitlin Schlabach, Gabriel Kim, Juliane K. Vierecke, David Lynch, Carmela Tan,Eileen Hsich, Paulino Alvarez Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and Hope , JACC: Case Reports, 31(17): 2026,107391.
Gaetz W, Saleh MG, Birnbaum C, Bloy L, Roberts TPL, Lynch DR. Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy , Neuroimage: Clinical, 50:: 2026,103983.
Devore, M, Lam, C, Wiley, C, Park, CC, Lynch, DR, Bidichandani, S Unrecognized high prevalence of expanded composite repeats in Friedreich ataxia , Hum Mol Gen, 35(3): 2026,:ddaf190.
Rummey, C, Lynch, D. R. Axial Function Reflects Global Severity in Ambulatory Friedreich and Spinocerebellar Ataxia , Annals of Clinical and Translational Neurology: 2026